An Exploration of Ranibizumab Injection Frequency in Patients with Diabetic Macular Edema: A Post-hoc Analysis of the Restore and Retain Study

被引：0
|
作者：
Figueira, Joao [1 ]
Margaron, Philippe [2 ]
Hashmonay, Ron [2 ]
机构：
[1] AIBILI, Coimbra, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Diabetic Macular Edema; Ranibizumab; RESTORE Study; RETAIN Study; Visual Acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
160
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Calugaru, Dan
    Calugaru, Mihai
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (05) : 1035 - 1037
  • [32] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Karst, Sonja G.
    Lammer, Jan
    Mitsch, Christoph
    Schober, Manuela
    Mehta, Janhvi
    Scholda, Christoph
    Kundi, Michael
    Kriechbaum, Katharina
    Schmidt-Erfurth, Ursula
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 49 - 58
  • [33] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Dan Călugăru
    Mihai Călugăru
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 1035 - 1037
  • [34] Aqueous vascular endothelial growth factor after bimonthly intravitreal injection of ranibizumab or aflibercept in patients with diabetic macular edema
    Sawada, Osamu
    Ichiyama, Yusuke
    Ito, Yuka
    Fujikawa, Masato
    Kakinoki, Masashi
    Sawada, Tomoko
    Saishin, Yoshitsugu
    Ohji, Masahito
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [35] Impact of Intravitreal Ranibizumab Therapy on Vision Outcomes in Diabetic Macular Edema Patients: A Meta-Analysis
    Falcao, Manuel
    OPHTHALMOLOGICA, 2020, 243 (04) : 243 - 254
  • [36] Three year outcomes of intravitreal ranibizumab and aflibercept treatment of patients with diabetic macular edema: A comparative study
    Akbas, Yusuf Berk
    Alagoz, Cengiz
    Cakmak, Semih
    Demir, Gokhan
    Alagoz, Nese
    Artunay, Halil Ozgur
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2023, 15
  • [37] Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
    Udaondo, Patricia
    Garcia-Pous, Maria
    Garcia-Delpech, Salvador
    Salom, David
    Diaz-Llopis, Manuel
    JOURNAL OF OPHTHALMOLOGY, 2011, 2011
  • [38] Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study
    Mitchell, Paul
    Massin, Pascale
    Bressler, Susan
    Coon, Cheryl D.
    Petrillo, Jennifer
    Ferreira, Alberto
    Bressler, Neil M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (11) : 1967 - 1975
  • [39] A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment
    Kaldirim, Havva
    Yazgan, Serpil
    Kirgiz, Ahmet
    Atalay, Kursat
    Savur, Fatma
    CURRENT EYE RESEARCH, 2019, 44 (09) : 987 - 993
  • [40] Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) The BRDME Study, a Randomized Trial
    Vader, Maartje J. C.
    Schauwvlieghe, Ann-Sofie M. E.
    Verbraak, Frank D.
    Dijkman, Greetje
    Hooymans, Johanna M. M.
    Los, Leonoor, I
    Zwinderman, Aeilko H.
    Peto, Tunde
    Hoyng, Carel B.
    van Leeuwen, Redmer
    Vingerling, Johannes R.
    Moll, Annette C.
    Van Lith-Verhoeven, Janneke J. C.
    Dijkgraaf, Marcel G. W.
    Schlingemann, Reinier O.
    OPHTHALMOLOGY RETINA, 2020, 4 (08): : 777 - 788
12345